Gregory Glover | Blog
May 5, 2019
FDA's Rare Pediatric PRV Program - Renew?
Should the FDA Renew its Rare Pediatric Disease Priority Review Voucher Program? It might seem soon to be discussing renewal (the program does not expire until October 2020), but renewal is something drug developers and investors are thinking about. Is the FDA's Rare Pediatric Disease Priority Review Voucher Program effective? What are the benefits and limitations? More